

Advisory Council January 2021 Meeting Presentation: Blood Based Biomarkers
ADVISORY COUNCIL ON ALZHEIMER'S RESEARCH, CARE, AND SERVICES
Monday, January 25, 2021
Printer Friendly Version in PDF Format (14 PDF pages)
Update on blood based biomarkers for Alzheimer's Disease
David M. Holtzman, MD
Professor and Chair of Neurology
Washington University in St. Louis


Advisory Council January 2021 Meeting Presentation: Nomenclature
ADVISORY COUNCIL ON ALZHEIMER'S RESEARCH, CARE, AND SERVICES
Monday, January 25, 2021
Printer Friendly Version in PDF Format (9 PDF pages)
Nomenclature
Ronald C. Petersen, PhD, MD
Mayo Clinic
Rochester, MN
Angela Taylor
Lewy Body Dementia Association


Advisory Council January 2021 Meeting Presentation: NIAs Clinical Research Update
ADVISORY COUNCIL ON ALZHEIMER'S RESEARCH, CARE, AND SERVICES
Monday, January 25, 2021
Printer Friendly Version in PDF Format (17 PDF pages)


Advisory Council January 2021 Meeting Presentation: COVID-19 Vaccine Implementation
ADVISORY COUNCIL ON ALZHEIMER'S RESEARCH, CARE, AND SERVICES
Monday, January 25, 2021
Printer Friendly Version in PDF Format (9 PDF pages)
COVID-19 Vaccine Implementation
Dr. Georgina Peacock
Centers for Disease Control and Prevention


Advisory Council January 2021 Meeting Presentation: Impact of COVID on Medicare FFS
ADVISORY COUNCIL ON ALZHEIMER'S RESEARCH, CARE, AND SERVICES
Monday, January 25, 2021
Printer Friendly Version in PDF Format (9 PDF pages)


Advisory Council January 2021 Meeting Agenda
AGENDA
Advisory Council on Alzheimer's Research, Care, and Services
January 25, 2021 1:00 pm - 4:30 pm (Eastern Standard Time)
Streamed live -- http://www.hhs.gov/live
Printer Friendly Version in PDF Format (2 PDF pages)


Advisory Council January 2021 Meeting Announcement
Advisory Council January 2021 Meeting Announcement
Printer Friendly Version in PDF Format (1 PDF page)
The next meeting of the Advisory Council on Alzheimer's Research, Care, and Services will be held on January 25, 2021, from 1:00pm to 4:30pm EST. The meeting, due to COVID-19, will be virtual and webcast at http://www.hhs.gov/live .


National Plan to Address Alzheimer's Disease: 2020 Update. NAPA INFORMATION
Return to
National Alzheimer's Project Act Home Page
National Plan to Address Alzheimer's Disease and Other NAPA Documents Page
National Plans to Address Alzheimer's Disease Page


National Plan to Address Alzheimer's Disease: 2020 Update. List of Acronyms Used
AAA
Area Agency on Aging
AAIC
Alzheimer's Association International Conference
ABCD
Addressing Challenging Behaviors in Dementia
ACL
Administration for Community Living
ACP


National Plan to Address Alzheimer's Disease: 2020 Update. References
Hebert LE, Weuve J, Scherr PA, Evans DA. "Alzheimer's Disease in the United States (2010-2050) Estimated Using the 2010 Census." Neurol, 2013; 80:1778-1783.
Burns A, Iliffe S. "Alzheimer's Disease." BMJ, 2009; 338:b158.
Alzheimer's Disease Education and Referral (ADEAR) Center. Alzheimer's Disease Fact Sheet. U.S. Department o


National Plan to Address Alzheimer's Disease: 2020 Update. Appendix 2: Implementation Milestones
Action Number
Action Description
(from Plan)
Method of Action
Lead Agency
Partner(s)


National Plan to Address Alzheimer's Disease: 2020 Update. Appendix 1: List of Participating Departments and Agencies
Administration for Children and Families (ACF)
Administration for Community Living (ACL)
Administration on Aging (AoA)
Administration on Intellectual and Developmental Disabilities (ADD)
Agency for Healthcare Research and Quality (AHRQ)
Centers for Disease Control and Prevention (CDC)
Centers for Medicare & Medicaid Services (CMS)


National Plan to Address Alzheimer's Disease: 2020 Update. Strategy 5.B: Monitor Progress on the National Plan
The National Plan is intended to be a Road Map for accomplishing its five goals. It is a document that is designed to be updated regularly. HHS is committed to tracking progress and incorporating findings into an updated National Plan.
( ONGOING ) Action 5.B.1: Track National Plan progress


National Plan to Address Alzheimer's Disease: 2020 Update. Strategy 5.A: Enhance the Federal Government's Ability to Track Progress
The Federal Government needs improved data on people with AD/ADRD, their caregivers, and the care and supports that they use to address policy questions and plan and evaluate new initiatives. HHS and its partners will identify the policy questions that cannot be answered with existing data, as well as questions likely to arise in the future. These


National Plan to Address Alzheimer's Disease: 2020 Update. Goal 5: Improve Data to Track Progress
The Federal Government is committed to better understanding AD/ADRD and its impact on PWD, families, the health and long-term care systems, and society as a whole. Data and surveillance efforts are paramount to tracking the burden of AD/ADRD on individual and population health and will be used to identify and monitor trends in risk factors associa


National Plan to Address Alzheimer's Disease: 2020 Update. Strategy 4.C: Coordinate United States Efforts with Those of the Global Community
Many nations have developed dementia plans of their own that involve improved care and supports for people with AD/ADRD and their caregivers, as well as enhanced research and public awareness. In implementing the actions in this Plan, HHS and its federal partners will coordinate with global partners to enhance these plans, avoid duplication of eff


National Plan to Address Alzheimer's Disease: 2020 Update. Strategy 4.B: Work with State, Tribal, and Local Governments to Improve Coordination and Identify Model Initiatives to Advance Alzheimer's Disease and Related Dementias Awareness and Readiness across the Government
State, Tribal, and local governments are working to help address challenges faced by people with AD/ADRD and their caregivers. Nineteen states and a handful of local entities have published plans to address AD/ADRD that cover many of the same issues as the National Plan. Leveraging the available resources and programs across these levels of govern


National Plan to Address Alzheimer's Disease: 2020 Update. Strategy 4.A: Educate the Public about Alzheimer's Disease and Related Dementias
Greater public awareness of AD/ADRD can encourage families to seek assessment, reduce isolation and misunderstanding felt by caregivers, and help link people in need to accurate information, resources and services.
( UPDATED ) Action 4.A.1: Enhance public outreach about Alzheimer's disease and related dementias


National Plan to Address Alzheimer's Disease: 2020 Update. Goal 4: Enhance Public Awareness and Engagement
Most of the public is aware of AD/ADRD; more than 85% of people surveyed can identify the disease and its symptoms. AD/ADRD is also one of the most feared health conditions, yet there are widespread and significant public misperceptions about diagnosis and clinical management. Misperceptions lead to delayed diagnosis and to people with the disease